In this study, we also observed a significant reduction in tumor-infiltrating Tregs (CD4+Foxp3+ T cells) in GSDMD-deficient or DSF-treated mice, presumably due to IL-2 reduction (data not shown). The gene discussed is IL2; the disease is neoplasm.